Search

Author/Creator Tartakovsky, Igor

1. Dabigatran etexilate for the treatment of acute venous thromboembolism in children (DIVERSITY): a randomised, controlled, open-label, phase 2b/3, non-inferiority trial. Issue 1 (January 2021)

Authors:
Halton, Jacqueline; Brandão, Leonardo R; Luciani, Matteo; Bomgaars, Lisa; Chalmers, Elizabeth; Mitchell, Lesley G; Nurmeev, Ildar; Sharathkumar, Anjali; Svirin, Pavel; Gorbatikov, Kirill; Tartakovsky, Igor; Simetzberger, Monika; Huang, Fenglei; Sun, Zhichao; Kreuzer, Jörg; Gropper, Savion; Reilly...
Journal:
Lancet
Issue:
Volume 8:Issue 1(2021)
Page Start:
e22
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Design and rationale for the DIVERSITY study: An open‐label, randomized study of dabigatran etexilate for pediatric venous thromboembolism. Issue 2 (25th March 2018)

Authors:
Albisetti, Manuela; Biss, Branislav; Bomgaars, Lisa; Brandão, Leonardo R.; Brueckmann, Martina; Chalmers, Elizabeth; Gropper, Savion; Harper, Ruth; Huang, Fenglei; Luciani, Matteo; Manastirski, Ivan; Mitchell, Lesley G.; Tartakovsky, Igor; Wang, Bushi; Halton, Jacqueline M. L.
Journal:
Research and practice in thrombosis and haemostasis
Issue:
Volume 2:Issue 2(2018)
Page Start:
347
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Pharmacokinetic modeling and simulation support for age‐ and weight‐adjusted dosing of dabigatran etexilate in children with venous thromboembolism. (26th March 2021)

Authors:
Röshammar, Daniel; Huang, Fenglei; Albisetti, Manuela; Bomgaars, Lisa; Chalmers, Elizabeth; Luciani, Matteo; Halton, Jacqueline; Mitchell, Lesley G.; Bergstrand, Martin; Ibrahim, Moustafa M. A.; Joseph, David; Tartakovsky, Igor; Gropper, Savion; Brueckmann, Martina; Brandão, Leonardo R.
Journal:
Journal of thrombosis and haemostasis
Issue:
Volume 19:Number 5(2021)
Page Start:
1259
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Phase 3, single‐arm, multicenter study of dabigatran etexilate for secondary prevention of venous thromboembolism in children: Rationale and design. Issue 3 (24th April 2018)

Authors:
Luciani, Matteo; Albisetti, Manuela; Biss, Branislav; Bomgaars, Lisa; Brueckmann, Martina; Chalmers, Elizabeth; Gropper, Savion; Halton, Jacqueline M. L.; Harper, Ruth; Huang, Fenglei; Manastirski, Ivan; Mitchell, Lesley G.; Tartakovsky, Igor; Wang, Bushi; Brandão, Leonardo R.
Journal:
Research and practice in thrombosis and haemostasis
Issue:
Volume 2:Issue 3(2018)
Page Start:
580
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Rationale and design of a phase III safety trial of idarucizumab in children receiving dabigatran etexilate for venous thromboembolism. Issue 1 (17th November 2017)

Authors:
Albisetti, Manuela; Schlosser, Arno; Brueckmann, Martina; Gropper, Savion; Glund, Stephan; Tartakovsky, Igor; Brandão, Leonardo R.; Reilly, Paul A.
Journal:
Research and practice in thrombosis and haemostasis
Issue:
Volume 2:Issue 1(2018)
Page Start:
69
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗